BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11396370)

  • 1. Effect of transitory hyperprolactinemia on in vitro fertilization of human oocytes.
    Mendes MC; Ferriani RA; Sala MM; Moura MD; Carrara HH; de Sá MF
    J Reprod Med; 2001 May; 46(5):444-50. PubMed ID: 11396370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of serum prolactin on cycle stimulation and fertilization of human oocytes].
    Reinthaller A; Deutinger J; Csaicsich P; Riss P; Müller-Tyl E; Fischl F; Janisch H
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):246-8. PubMed ID: 3109998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Superovulation-induced transient hyperprolactinemia in human in vitro fertilization and embryo transfer].
    Oda T; Yoshimura S; Hara T; Hara S; Yahagi M; Matsumoto C; Ohno T; Nakamura Y; Sumi Y; Sueoka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):113-20. PubMed ID: 3102646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended induction of ovulation by human menopausal gonadotropins and a gonadotropin-releasing hormone analog in high responders for in vitro fertilization and oocyte donation.
    Amit A; Yaron Y; Azem F; Peyser MR; David MP; Lessing JB
    J Reprod Med; 1995 Sep; 40(9):633-7. PubMed ID: 8576879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
    Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
    Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Iwase A; Ando H; Kuno K; Mizutani S
    Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
    La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
    Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.
    Delvigne A; Kostyla K; Murillo D; Van Hoeck J; Rozenberg S
    Int J Fertil Womens Med; 2003; 48(1):25-31. PubMed ID: 12643517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method.
    Jinno M; Katsumata Y; Hoshiai T; Nakamura Y; Matsumoto K; Yoshimura Y
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3603-11. PubMed ID: 9360514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of serum and follicular fluid leptin and ovarian steroid levels in response to induction of ovulation in in vitro fertilization cycles.
    Gürbüz B; Yalti S; Ficicioglu C; Taşdemir S
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):214-8. PubMed ID: 15653206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].
    Tsagareishvili GG
    Georgian Med News; 2005 Feb; (119):18-23. PubMed ID: 15834173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of macrophage colony-stimulating factor during in-vitro fertilization and embryo transfer cycles].
    Quan S; Wan L; Song L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jan; 35(1):42-4. PubMed ID: 11831950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.